Turmeric -CURCUMA LONGA - Topical

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

Monograph: Turmeric - Topical(English) (PDF Version - 36 K)

This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications (PLAs) and labels for natural health product market authorization. It is not intended to be a comprehensive review of the medicinal ingredient.

Notes

Date

August 13, 2021

Proper name(s), Common name(s), Source information

Table 1. Proper name(s), Common name(s), Source information
Proper name(s) Common name(s) Source information
Source material(s) Part(s) Preparation(s)
Curcuma longa
  • Common turmeric
  • Curcuma
  • Indian-saffron
  • Jianghuang
  • Turmeric
  • Yellow ginger
 Curcuma longa Rhizome Dried

References: Proper name: USDA 2018; Common names: USDA 2018, McGuffin et al. 2000; Source information: PPRC 2005, ESCOP 2003, Blumenthal et al. 2000.

Route of administration

Topical (Paranjape 2005; Williamson 2002)

Dosage form(s)

Acceptable dosage forms for topical use are indicated in the dosage form drop-down list of the web-based Product Licence Application form for Compendial applications.

Use(s) or Purpose(s)

The following combined use(s) or purpose(s) is/are also acceptable

Traditionally used in Ayurveda to relieve pain and inflammation, assist healing of minor wounds such as cuts and burns, and/or assist healing of minor skin irritations (Paranjape 2005; Murthy 2004; API 2001; Kapoor 2001).

Note
Claims for traditional use must include the term "Herbal Medicine", "Traditional Chinese Medicine", or "Ayurveda".

Dose(s)

Subpopulation(s)

Adults 18 years and older

Quantity(ies)

Methods of preparation: Powdered, Non-Standardized Ethanolic Extracts (Dry extract, Tincture, Fluid extract)

5 - 100% of dried rhizome or extract in the finished product (Jamali et al. 2020; API 2001; Nadkarni and Nadkarni 1976).

Note:

For dry extracts, above a concentration of 5%, maximum extract ratio allowed is 25:1.

Direction(s) for use

Apply to affected area as needed.

Duration of use

No statement required.

Risk information

Caution(s) and warning(s)

Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

Contraindication(s)

No statement required.

Known adverse reaction(s)

No statement required.

Non-medicinal ingredients

Must be chosen from the current Natural Health Products Ingredients Database (NHPID) and must meet the limitations outlined in the database.

Storage conditions

Must be established in accordance with the requirements described in the Natural Health Products Regulations (NHPR).

Specifications

References cited

References reviewed